Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01177046
Other study ID # 160-2002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2010
Est. completion date October 2021

Study information

Verified date June 2022
Source Sunnybrook Health Sciences Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The findings of this research will be used to develop a scale for measuring the quality of epidural pain relief achieved during labour and vaginal delivery.


Description:

The current lack of a tool to measure the overall quality of neuraxial pain relief provided in labour analgesia trials has produced studies unable to provide clear direction to clinical care and research. Our previous work explored and described the underlying dimensions and attributes of quality neuraxial analgesia from the perspectives of labouring women as the initial phase of development of an Index to measure this as an outcome in research. We now seek to confirm our findings as well as to generate additional items (descriptors) of quality neuraxial analgesia from the perspectives of parturients and experts (obstetrical anesthesiologists and experienced labour nurses). Once generated, the full list of items will be used to in a subsequent study involving only parturients (Item Reduction phase) to develop a scale permitting global measurement of quality neuraxial labour analgesia. The resulting scale, once validated, will provide researchers with a simple global measure for quality in labour analgesia research. This scale will be used later in our program of research to assist with validation studies of the larger Multi-attribute Health Index we are developing.


Recruitment information / eligibility

Status Completed
Enrollment 752
Est. completion date October 2021
Est. primary completion date October 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: 1. Use of neuraxial labour analgesia during the current pregnancy 2. Native English-speakers 3. Term pregnancies (>37-42weeks) 4. The ability to read and write in English 5. Provision of written informed consent. Exclusion Criteria: 1. Women who received IM or IV narcotics within 4 hours of epidural/ combined spinal epidural (CSE) placement 2. Women with evidence or history of maternal cognitive impairment 3. Women who experienced a neonatal death during the current pregnancy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Sunnybrook Health Sciences Centre Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
Sunnybrook Health Sciences Centre

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Psychometric instrument development study Exploration and description of language, nature, and variability of women's pain experiences during labour and delivery. 5-6 years
See also
  Status Clinical Trial Phase
Completed NCT00385294 - Role of B2 Adrenergic Receptors in Labor Pain
Completed NCT01389128 - Non-pharmacological Resources in Assisting Labor N/A
Completed NCT01197950 - Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain N/A
Completed NCT00151346 - Combined Spinal-Epidural Versus Traditional Labor Epidural Phase 4
Completed NCT05441085 - Effectiveness of Programed Intermittent Epidural Bolus Interval 90 (EI90) of 10 ml, 0.0625% Bupivacaine Plus 2 μg/mL Fentanyl interval90(EI90)of10ml,0.0625%Bupivacaine Plus 2μg/mL Fentanyl N/A
Completed NCT02697994 - Sterile Water Injections For Pain Relief İn Labor N/A
Completed NCT00202722 - Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour Phase 4
Not yet recruiting NCT06214585 - Effect of Intermittent Heat and Cold Therapy on Comfort During Labor N/A
Completed NCT00426725 - Testing the Efficiency of a Device Meant to Relieve Labour Pain N/A